Is NERV or NKTX more undervalued in 2026?

CirclFi compares Minerva Neurosciences, Inc (NERV) and Nkarta, Inc. (NKTX) using 13 institutional-grade valuation models. NERV has a Quality of Company score of 3.4/10 while NKTX scores 4.6/10.

Which is a better buy — NERV or NKTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NERV and NKTX valuations compare?

NERV at $4.91 and NKTX at $3.25 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NERV vs NKTX Valuation Comparison 2026 — Intrinsic Value Analysis

NERV

Pharmaceutical Preparations

Minerva Neurosciences, Inc

Quality

3.4

out of 10

Value Trap

SAFE

Price

$4.91

Last close

Models

6/13

Active

NKTX

Pharmaceutical Preparations

Nkarta, Inc.

Quality

4.6

out of 10

Value Trap

SAFE

Price

$3.25

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	NERV Fair Value	NERV Upside	NKTX Fair Value	NKTX Upside
Bayesian DCF	Intrinsic	$1.70	-65.3%	$0.54	-83.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$2.32	-28.5%
PWERM	Option-Based	$11.74	+139.1%	$3.00	-7.6%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NERV vs NKTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NERV vs NKTX — Which Stock Is More Undervalued?

NKTX scores higher with a 4.6/10 quality rating vs NERV's 3.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Minerva Neurosciences, Inc (NERV) and Nkarta, Inc. (NKTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NERV currently trades at $4.91 with a QOC of 3.4/10, while NKTX trades at $3.25 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).